• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL FLEXNAV DELIVERY SYSTEM; Aortic valve, prosthesis, percutaneously delivered

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL FLEXNAV DELIVERY SYSTEM; Aortic valve, prosthesis, percutaneously delivered Back to Search Results
Catalog Number UNK FLEXNAV DS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Obstruction/Occlusion (2422); Pseudoaneurysm (2605); Vascular Dissection (3160)
Event Date 09/01/2017
Event Type  Injury  
Event Description
The article, "femoral vessel complications after transfemoral tavr¿a contemporary sonography-based assessment of 480 patients with third-generation transcatheter valves", was reviewed.The article presented a prospective, single center study that investigated the incidence and risk factors of femoral vessel complications in a modern transcatheter aortic valve replacement (tavr) collective using postinterventional sonography.Devices included in this study were sapien s3/s3 ultra, evolut/pro/pro plus, portico/navitor, accurate/neo, allegra, and jenavalve.The article concluded the incidence of postinterventional femoral artery stenosis following transfemoral-tavr was higher than expected with a number of used closure devices and female sex being independent risk factors.Considering the continuous advance of tavr in low-risk patients with preserved physical activity, emphasis should be directed at the correct diagnosis and follow-up of these complications.[the primary and corresponding author was (b)(6).
 
Manufacturer Narrative
B3 - date of event is estimated.D4 - the udi number is not known as the part and lot numbers were not provided.Summarized patient outcomes/complications of flexnav ds were reported in a research article in a subject population with multiple co-morbidities including arterial hypertension, diabetes, dyslipidemia, peripheral artery disease, chronic lung disease, smoking history, dialysis.Some of the complications reported were bleeding, vascular stenosis, pseudoaneurysm, dissection, atrio-venous fistula, hematoma, surgical intervention, hospitalization.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Based on available information, root causes for the reported events could not be conclusively determined.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXNAV DELIVERY SYSTEM
Type of Device
Aortic valve, prosthesis, percutaneously delivered
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG#3007113487
177 county road b east
st. paul MN 55117 1789
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18445349
MDR Text Key331914368
Report Number2135147-2024-00058
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK FLEXNAV DS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/11/2023
Initial Date FDA Received01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-